お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙:特殊ジェネリック医薬品の世界市場:業界動向、市場シェア・規模・成長率・機会および予測(2021年~2026年)
市場調査レポート
商品コード
999876

特殊ジェネリック医薬品の世界市場:業界動向、市場シェア・規模・成長率・機会および予測(2021年~2026年)

Specialty Generics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

出版日: | 発行: IMARC Services Private Limited | ページ情報: 英文 140 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.22円
特殊ジェネリック医薬品の世界市場:業界動向、市場シェア・規模・成長率・機会および予測(2021年~2026年)
出版日: 2021年04月12日
発行: IMARC Services Private Limited
ページ情報: 英文 140 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の特殊ジェネリック医薬品の市場規模は、2020年に573億米ドルのに達しました。特殊ジェネリック医薬品は、特許の期限が切れた特殊医薬品のジェネリック版です。これらの薬は、癌、自己免疫疾患、てんかん、HIV、肝炎、多発性硬化症、関節リウマチなどの慢性疾患または合併症の治療に使用されています。特殊ジェネリックは、高価な開発費とマーケティング費用を必要としないため、ブランド医薬品と比較して費用対効果が高くなります。

従来のジェネリック医薬品と比較して、特殊ジェネリック医薬品市場は、複雑な製造要件、より高い資本コスト、および患者数の減少による比較的少ない量のために、少数の企業に集中しています。これにより、ブランド薬と比較して価格が低くなり、その結果、従来のジェネリック医薬品と比較して利益率が高くなります。特殊ジェネリック医薬品は、特別な取り扱い、管理、監視が必要であり、通常、それらを注文するには事前の承認が必要です。世界の特殊ジェネリック医薬品市場は現在、高齢化人口の増加、多数のブランド特殊医薬品の特許満了、癌、多発性硬化症、HIVなどのさまざまな致死的な疾患の有病率の増加、ヘルスケアプロバイダーからのコスト抑制対策、新興市場からの成長などが、市場成長を促進する要因となっています。世界の特殊ジェネリック医薬品市場は、今後5年間で力強い成長を示すと予想されています。

当レポートは、世界の特殊ジェネリック医薬品市場について調査しており、業界動向、市場予測、投与経路・適応症・流通チャネル・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 序文

第2章 範囲と調査方法

第3章 エグゼクティブサマリー

第4章 世界の特殊ジェネリック医薬品市場:イントロダクション

第5章 特殊ジェネリック医薬品が有利な点

第6章 世界の特殊ジェネリック医薬品市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 投与経路別の市場セグメンテーション
  • 適応症別の市場セグメンテーション
  • 流通チャネル別の市場セグメンテーション
  • 地域別の市場セグメンテーション
  • SWOT分析
    • 概要
    • 強み
    • 弱点
    • 市場機会
    • 脅威
  • バリューチェーン分析
  • ポーターのァイブフォース分析
  • 主要な市場成長要因と成功要因

第7章 投与経路別の市場セグメンテーション

  • 注射剤
  • 経口
  • その他

第8章 適応症別の市場セグメンテーション

  • 腫瘍学
  • 自己免疫疾患
  • 感染症
  • その他

第9章 流通チャネル別の市場セグメンテーション

  • 小売薬局
  • 専門薬局
  • 病院薬局

第10章 地域別の市場セグメンテーション

  • 北米
    • 市場概要
    • 市場実績
    • 国別の市場セグメンテーション
    • 米国
    • カナダ
  • 欧州
    • 市場概要
    • 市場実績
    • 国別の市場セグメンテーション
    • イタリア
    • ドイツ
    • フランス
    • 英国
    • スペイン
  • アジア太平洋地域
    • 市場概要
    • 市場実績
    • 国別の市場セグメンテーション
    • 日本
    • 中国
    • インド
    • 韓国
  • ラテンアメリカ
    • 市場概要
    • 市場実績
    • 国別の市場セグメンテーション
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • 市場概要
    • 市場実績

第11章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Teva Pharmaceuticals Industries
    • Akorn, Inc.
    • Mylan N.V.
    • Mallinckrodt
    • Sandoz International GmbH
    • Pfizer, Inc.
    • Sun Pharmaceutical Industries Ltd.
    • Valeant Pharmaceuticals
    • Apotex Corp.
    • Endo International plc.
図表

List of Figures

  • Figure 1: Global: Specialty Generics Market: Sales Value (in Billion US$), 2015-2020
  • Figure 2: Global: Specialty Generics Market: Breakup by Route of Administration (in %), 2020
  • Figure 3: Global: Specialty Generics Market: Breakup by Indication (in %), 2020
  • Figure 4: Global: Specialty Generics Market: Breakup by Distribution Channel (in %), 2020
  • Figure 5: Global: Specialty Generics Market: Breakup by Region (in %), 2020
  • Figure 6: Global: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 7: Global: Specialty Generics Industry: SWOT Analysis
  • Figure 8: Global: Specialty Generics Industry: Value Chain Analysis
  • Figure 9: Global: Specialty Generics Industry: Porter's Five Forces Analysis
  • Figure 10: Global: Specialty Generics Market (Administration through Injectables): Sales Value (in Billion US$), 2015 & 2020
  • Figure 11: Global: Specialty Generics Market (Administration through Injectables) Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 12: Global: Specialty Generics Market (Oral Administration): Sales Value (in Billion US$), 2015 & 2020
  • Figure 13: Global: Specialty Generics Market (Oral Administration) Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 14: Global: Specialty Generics Market (Other Routes of Administration): Sales Value (in Billion US$), 2015 & 2020
  • Figure 15: Global: Specialty Generics Market (Other Routes of Administration) Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 16: Global: Specialty Generics Market (Oncology): Sales Value (in Billion US$), 2015 & 2020
  • Figure 17: Global: Specialty Generics Market (Oncology) Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 18: Global: Specialty Generics Market (Autoimmune Diseases): Sales Value (in Billion US$), 2015 & 2020
  • Figure 19: Global: Specialty Generics Market (Autoimmune Diseases) Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 20: Global: Specialty Generics Market (Infectious Diseases): Sales Value (in Billion US$), 2015 & 2020
  • Figure 21: Global: Specialty Generics Market (Infectious Diseases) Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 22: Global: Specialty Generics Market (Other Indications): Sales Value (in Billion US$), 2015 & 2020
  • Figure 23: Global: Specialty Generics Market (Other Indications) Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 24: Global: Specialty Generics Market: Sales Through Retail Pharmacies (in Billion US$), 2015 & 2020
  • Figure 25: Global: Specialty Generics Market Forecast: Sales Through Retail Pharmacies (in Billion US$), 2021-2026
  • Figure 26: Global: Specialty Generics Market: Sales Through Specialty Pharmacies (in Billion US$), 2015 & 2020
  • Figure 27: Global: Specialty Generics Market Forecast: Sales Through Specialty Pharmacies (in Billion US$), 2021-2026
  • Figure 28: Global: Specialty Generics Market: Sales Through Hospital Pharmacies (in Billion US$), 2015 & 2020
  • Figure 29: Global: Specialty Generics Market Forecast: Sales Through Hospital Pharmacies (in Billion US$), 2021-2026
  • Figure 30: North America: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 31: North America: Specialty Generics Market: Breakup by Country (in %), 2020
  • Figure 32: North America: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 33: United States: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 34: United States: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 35: Canada: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 36: Canada: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 37: Europe: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 38: Europe: Specialty Generics Market: Breakup by Country (in %), 2020
  • Figure 39: Europe: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 40: Italy: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 41: Italy: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 42: Germany: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 43: Germany: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 44: France: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 45: France: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 46: United Kingdom: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 47: United Kingdom: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 48: Spain: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 49: Spain: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 50: Asia Pacific: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 51: Asia Pacific: Specialty Generics Market: Breakup by Country (in %), 2020
  • Figure 52: Asia Pacific: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 53: Japan: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 54: Japan: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 55: China: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 56: China: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 57: India: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 58: India: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 59: South Korea: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 60: South Korea: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 61: Latin America: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 62: Latin America: Specialty Generics Market: Breakup by Country (in %), 2020
  • Figure 63: Latin America: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 64: Brazil: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 65: Brazil: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 66: Mexico: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 67: Mexico: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 68: Middle East and Africa: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 69: Middle East and Africa: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026

List of Tables

  • Table 1: Global: Specialty Generics Market: Key Industry Highlights, 2020 and 2026
  • Table 2: Global: Specialty Generics Market Forecast: Breakup by Route of Administration (in Billion US$), 2021-2026
  • Table 3: Global: Specialty Generics Market Forecast: Breakup by Indication (in Billion US$), 2021-2026
  • Table 4: Global: Specialty Generics Market Forecast: Breakup by Distribution Channel (in Billion US$), 2021-2026
  • Table 5: Global: Specialty Generics Market Forecast: Breakup by Region (in Billion US$), 2021-2026
  • Table 6: North America: Specialty Generics Market: Key Industry Highlights, 2020 and 2026
  • Table 7: Europe: Specialty Generics Market: Key Industry Highlights, 2020 and 2026
  • Table 8: Asia Pacific: Specialty Generics Market: Key Industry Highlights, 2020 and 2026
  • Table 9: Latin America: Specialty Generics Market: Key Industry Highlights, 2020 and 2026
  • Table 10: Middle East and Africa: Specialty Generics Market: Key Industry Highlights, 2020 and 2026
  • Table 11: Global: Specialty Generics Market Structure
  • Table 12: Global: Specialty Generics Market: Key Players
目次
Product Code: SR1020B262_Report

The global specialty generics market reached a value of US$ 57.3 Billion in 2020. Specialty generics are generic versions of specialty drugs, once they get off-patent. These drugs are used to treat chronic or complex health conditions including cancer, autoimmune diseases, epilepsy, HIV, Hepatitis, multiple sclerosis, rheumatoid arthritis, etc. Speciality generics are cost-effective as compared to their branded versions as they don't require costly development and marketing costs.

Compared to traditional generics, the speciality generics market is more concentrated with fewer players due to their complex manufacturing requirements, higher capital costs and relatively lower volumes as a result of smaller patient population. This results in lower price reduction compared to the branded drug and consequently higher margins compared to traditional generics. Speciality generics require special handling, administration, monitoring and generally need prior authorization to order them. The global speciality generics market is currently being driven by several factors such as rising ageing population, patent expiration of a number of branded specialty drugs, increasing prevalence of various life-threatening diseases such as cancer, multiple sclerosis, HIV, etc., cost containment measures from healthcare providers, growth from emerging markets, etc. Looking forward, IMARC Group expects the global specialty generics market to exhibit strong growth during the next five years.

IMARC Group's latest report provides a deep insight into the global specialty generics market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the specialty generics market in any manner.

Report Scope:

  • Historical, Current and Future Market Trends

Market Breakup by Region:

  • North America
  • United States
  • Canada
  • Europe
  • Italy
  • Germany
  • Spain
  • United Kingdom
  • France
  • Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Latin America
  • Brazil
  • Mexico
  • Middle East and Africa

Market Breakup by Route of Administration:

  • Injectables
  • Oral
  • Others

Market Breakup by Indication:

  • Oncology
  • Autoimmune Diseases
  • Infectious Diseases
  • Others

Market Breakup by Distribution channel:

  • Retail Pharmacies
  • Specialty Pharmacies
  • Hospital Pharmacies

Competitive Landscape:

  • The global specialty generics market consists of numerous manufacturers. Some of the leading players operating in the market are Teva Pharmaceuticals Industries, Akorn, Inc., Mylan N.V., Mallinckrodt, Sandoz International GmbH, Pfizer, Inc., Sun Pharmaceutical Industries Ltd., Valeant Pharmaceuticals, Apotex Corp., Endo International plc.

Key Questions Answered in This Report:

  • How has the global specialty generics market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the global specialty generics industry?
  • What has been the impact of COVID-19 on the global specialty generics industry?
  • What is the breakup of the global specialty generics market based on the indication?
  • What is the breakup of the global specialty generics market based on the route of administration?
  • What is the breakup of the global specialty generics market based on the distribution channel?
  • What are the various stages in the value chain of the global specialty generics industry?
  • What are the key driving factors and challenges in the global specialty generics market?
  • What is the structure of the global specialty generics industry and who are the key players?
  • What is the degree of competition in the global specialty generics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Global Specialty Generics Market: Introduction

5 Why are Specialty Generics So Lucrative?

6 Global Specialty Generics Market

  • 6.1 Market Overview
  • 6.2 Market Performance
  • 6.3 Impact of COVID-19
  • 6.4 Market Breakup by Route of Administration
  • 6.5 Market Breakup by Indication
  • 6.6 Market Breakup by Distribution Channel
  • 6.7 Market Breakup by Region
  • 6.8 Market Forecast
  • 6.9 SWOT Analysis
    • 6.9.1 Overview
    • 6.9.2 Strengths
    • 6.9.3 Weaknesses
    • 6.9.4 Opportunities
    • 6.9.5 Threats
  • 6.10 Value Chain Analysis
  • 6.11 Porters Five Forces Analysis
    • 6.11.1 Overview
    • 6.11.2 Bargaining Power of Buyers
    • 6.11.3 Bargaining Power of Suppliers
    • 6.11.4 Degree of Competition
    • 6.11.5 Threat of New Entrants
    • 6.11.6 Threat of Substitutes
  • 6.12 Key Market Drivers and Success Factors

7 Market Breakup by Route of Administration

  • 7.1 Injectable
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Oral
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Indication

  • 8.1 Oncology
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Autoimmune Diseases
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Infectious Diseases
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Retail Pharmacies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Specialty Pharmacies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Hospital Pharmacies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 Market Overview
    • 10.1.2 Market Performance
    • 10.1.3 Market Breakup by Country
    • 10.1.4 United States
      • 10.1.4.1 Market Trends
      • 10.1.4.2 Market Forecast
    • 10.1.5 Canada
      • 10.1.5.1 Market Trends
      • 10.1.5.2 Market Forecast
  • 10.2 Europe
    • 10.2.1 Market Overview
    • 10.2.2 Market Performance
    • 10.2.3 Market Breakup by Country
    • 10.2.4 Italy
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Germany
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 France
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 United Kingdom
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
    • 10.2.8 Spain
      • 10.2.8.1 Market Trends
      • 10.2.8.2 Market Forecast
  • 10.3 Asia Pacific
    • 10.3.1 Market Overview
    • 10.3.2 Market Performance
    • 10.3.3 Market Breakup by Country
    • 10.3.4 Japan
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 China
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 India
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 South Korea
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Market Overview
    • 10.4.2 Market Performance
    • 10.4.3 Market Breakup by Country
    • 10.4.4 Brazil
      • 10.4.4.1 Market Trends
      • 10.4.4.2 Market Forecast
    • 10.4.5 Mexico
      • 10.4.5.1 Market Trends
      • 10.4.5.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Overview
    • 10.5.2 Market Performance
    • 10.5.3 Market Forecast

11 Competitive Landscape

  • 11.1 Market Structure
  • 11.2 Key Players
  • 11.3 Profiles of Key Players
    • 11.3.1 Teva Pharmaceuticals Industries
    • 11.3.2 Akorn, Inc.
    • 11.3.3 Mylan N.V.
    • 11.3.4 Mallinckrodt
    • 11.3.5 Sandoz International GmbH
    • 11.3.6 Pfizer, Inc.
    • 11.3.7 Sun Pharmaceutical Industries Ltd.
    • 11.3.8 Valeant Pharmaceuticals
    • 11.3.9 Apotex Corp.
    • 11.3.10 Endo International plc.

株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.